Clinical Psychiatry NewsMassive rise in drug overdose deaths driven by opioidsFebruary 1, 2023Addiction Medicine
Clinical Psychiatry NewsAlzheimer’s Association to CMS: Ditch restraints on amyloid drugsDecember 22, 2022Alzheimer's & CognitionGeriatricsNeurologyBusiness of Medicine
Clinical Psychiatry NewsFDA puts REMS requirements on hold to ensure continuity of careNovember 8, 2022Schizophrenia & Other Psychotic DisordersBusiness of Medicine
Clinical Psychiatry NewsFDA orders Juul to stop selling E-cigarettesJune 23, 2022Mixed TopicsAddiction Medicine
Clinical Psychiatry NewsFDA panel rejects pimavanserin for Alzheimer’s psychosisJune 20, 2022Alzheimer's & CognitionSchizophrenia & Other Psychotic DisordersGeriatricsNeurology
Clinical Psychiatry NewsFDA denies petition to disqualify researchers over controversial ketamine studiesJune 6, 2022Mixed Topics
Clinical Psychiatry NewsFDA okays first sublingual med for agitation in serious mental illnessApril 11, 2022Schizophrenia & Other Psychotic DisordersBipolar Disorder
Clinical Psychiatry NewsAs FDA OKs another COVID booster, some experts question needMarch 29, 2022COVID-19 Updates
Clinical Psychiatry NewsClozapine interrupted: APA, others seek FDA forum on REMSMarch 7, 2022Schizophrenia & Other Psychotic Disorders
Clinical Psychiatry NewsCDC to update mask recommendations as Omicron spreadsJanuary 13, 2022COVID-19 Updates
Clinical Psychiatry NewsCDC defends new COVID guidance as doctors raise concernsJanuary 5, 2022COVID-19 Updates
Clinical Psychiatry NewsCOVID-19–positive or exposed? What to do nextDecember 30, 2021COVID-19 Updates
Clinical Psychiatry NewsCOVID-19 antigen tests may be less sensitive to Omicron: FDADecember 30, 2021COVID-19 Updates
